Bionano Symposium 2024 is Set to be Held from January 22-25 with vFairs as Tech Partner

Carrollton, TX – vFairs is pleased to announce that it will host the upcoming Bionano Symposium 2024, a four-day virtual event highlighting the Company’s optical genome mapping (OGM) technique. Bionano Genomics, Inc. (Nasdaq: BNGO), is a leading provider of genome analysis solutions. Scheduled to take place virtually from January 22 to 25, 2024, the Symposium will showcase 33 global experts sharing their insights on the transformative use of OGM across various clinical research applications, including cell and gene therapy, hematological malignancies, and constitutional genetic disease. Each day of the Symposium will also feature a virtual product exhibition hall, a poster hall showcasing over 60 scientific posters, and a live panel with a Q&A session. On day 2 of the Symposium, Bionano will unveil a new product that promises to advance its OGM workflow and transform laboratories’ approach to genome analysis.

Bionano Symposium is tailored for researchers, principal investigators, cytogeneticists, molecular biologists, oncology specialists, and professionals in related fields. Attendees can expect to delve into an array of topics, including genetic disorder and cancer research, genome integrity assessment for cell and gene therapy programs, and more. This symposium serves as a platform for the OGM community, enabling attendees to explore OGM’s utility and integration with other genome analysis tools for enhanced research discoveries.

“We are glad that the vFairs event management platform is supporting the Bionano Symposium 2024 by meeting their specific needs, and providing valuable support for the event,” said Muhammad Younas, vFairs CEO.

To learn more about Bionano Symposium 2024 and to register, please visit https://bionanosymposium2024.vfairs.com/. Presentations will also be available on demand following the event’s conclusion.

About Bionano

Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform how the world sees the genome through OGM solutions, diagnostic services, and software. The Company offers OGM solutions for applications across basic, translational, and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. The Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation, and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis technology. For more information, visit www.bionano.com, www.bionanolaboratories.com, or www.purigenbio.com.

Unless specifically noted otherwise, Bionano’s OGM products are for research use only and not for use in diagnostic procedures.

About vFairs

vFairs is an all-in-one event management platform that powers in-person, hybrid, and virtual events. Our event technology empowers companies worldwide to host custom, immersive events and achieve incredible results. The platform features a virtual events platform and mobile app, each offering immersive virtual venues, advanced networking, world-renowned customer service, and many features that help you host unforgettable events.